Authors and peer reviewers are failing to disclose the use of LLMs despite journal policies limiting their use
go.nature.com/4pxVmtc
@daniel-hansen.bsky.social
Postdoc studying liver disease (MASLD/MASH) at the University of Southern Denmark • Functional Genomics and Metabolism Research Unit
Authors and peer reviewers are failing to disclose the use of LLMs despite journal policies limiting their use
go.nature.com/4pxVmtc
Important news for liver health and research! Wegovy approved by FDA for treatment of MASH in patients with F2-F3 fibrosis 😊
www.novonordisk.com/news-and-med...
Thrilled and truly grateful to receive an Ascending Investigator Grant 🏆 from the @novonordiskfoundation, which will fuel our continued work on liver fibrosis and putative therapies. Thanks 🙌 for the generous support and belief in our abilities @sdu.dk > BMB > FGMunit > @ravnskjaer-lab.bsky.social.
19.05.2025 06:31 — 👍 5 🔁 2 💬 0 📌 0Thrilled to share our lab's first preprint, led by an exceptional PhD student Gita Chhetri and with the support of wonderful collaborators, we find that replisome function is rate-limited by strand-specific PCNA dynamics. Hope you will enjoy reading.
www.biorxiv.org/content/10.1...
Brief teaser:
🚨🤓 Extremely happy to see our new paper on stellate cell biology now online at Cell Metabolism 🙌🏼 Hepatic stellate cells are more than quiescent pericytes in healthy liver. They regulate hepatocytes energy preference during fasting ‼️🧩🐭
Text here 👉 www.cell.com/cell-metabol...
Check out our latest paper now online at Cell Metabolism: Hepatic stellate cells regulate liver fatty acid utilization via plasmalemma vesicle-associated protein. Amazing work by Daniel, Jasmin, Christian, Peter, Oliver from @ravnskjaer_lab, and many more 🏆💐♥️
www.cell.com/cell-metabol...